News

C&EN4d
Morphological Evidence for the Two-Step II–I Phase Transition of Isotactic Polybutene-1
Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be asked to login again with only ...
The Lancet6d
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
Copyright: © 2022 Elsevier Ltd. All rights reserved.
BMJ12d
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study ...
Consecutive patients satisfying all the inclusion criteria and none of the exclusion criteria shown in table 1 to be eligible for participation will be offered participation. Recruitment will be ...
Nasdaq14d
Nurix Therapeutics to Host Webcast on Phase 1 Clinical Trial Data for Bexobrutideg (NX-5948) at EHA2025
Nurix Therapeutics, Inc. has announced a webcast conference call scheduled for June 12, 2025, at 8:00 a.m. ET to discuss new data from its ongoing Phase 1 clinical trial of bexobrutideg (NX-5948 ...
Yardbarker14d
Lynx ink deal with EuroLeague veteran center
Standing at 6-foot-4, Kliundikova averaged 11.2 points and 7.5 rebounds in her last professional season in the Premier Basketball League. She made her international debut at 16 years old at ...
TSN16d
Elks ink Anderson to extension through '26 season
The Edmonton Elks have signed Nick Anderson to an extension that will keep the linebacker with the team through the 2026 season, it was announced Wednesday. Anderson, 25, was named as the CFL's ...
archive16d
How to play guitar. Phase 1
Ask the publishers to restore access to 500,000+ books. The Internet Archive keeps the record straight by preserving government websites, news publications, historical documents, and more. If you find ...
manilatimes17d
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Pioneering small-molecule program, NT-0796, targets chronic ...
BioSpace17d
Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
Phase 1 1 First-In-Human study designed to assess safety, tolerability, right dose for Phase 2 and early signs of efficacy of 177Lu-RAD202 in individuals with advanced HER2-positive solid tumors ...
BioSpace17d
NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796
Pioneering small-molecule program, NT-0796, targets chronic inflammation and its fundamental role in the complex cycle of weight regulation Oral, brain-penetrant NLRP3 inflammasome inhibitor being ...
SciELO17d
Isolation and characterization by asymmetric PCR of the ENDO1 gene for glucan endo-1,3-β-D-glucosidase in Phytophthora cinnamomi associated with the ink disease of Castanea ...
and associated with the ink disease of Castanea sativa Mill. Phytophthora cinnamomi; glucan endo-1,3-β-D-glucosidase; asymmetric PCR Doença da tinta é um das doenças mais destrutivas em Castanea ...
Mint18d
Glenmark-Ichnos cancer drug shows 74% response in phase-1 trial
Mumbai: Ichnos Glenmark Innovation (IGI), a joint venture between Glenmark Pharmaceuticals and Ichnos Sciences, on Monday shared promising results from an ongoing phase-1 trial of ISB 2001 ...